Jci_page_head_homepage_01 Jci_page_head_homepage_02
Wensheng Lin, Samantha L. Bailey, Hanson Ho, Heather P. Harding, David Ron, Stephen D. Miller, Brian Popko
Published in Volume 117, Issue 2
J Clin Invest. 2007; 117(2):448–456 doi:10.1172/JCI29571
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 5
The protective effects of IFN-γ in EAE are associated with activation of the PERK-eIF2α pathway in oligodendrocytes.

(A and B) CC1 and p-PERK double labeling showed modest activation of PERK in a few oligodendrocytes in the lumbar spinal cords of control mice at PID14, and CNS delivery of IFN-γ strongly activated PERK in the majority of oligodendrocytes. (C and D) CC1 and p-eIF2α double labeling showed that modest activation of eIF2α in a few oligodendrocytes in the lumbar spinal cord of control mice at PID14, and CNS delivery of IFN-γ markedly activated eIF2α in the majority of oligodendrocytes. Scale bar: 10 μm. (E) Quantitative analysis showed CNS delivery of IFN-γ significantly increased the percentage of double-positive CC1/p-PERK and CC1/p-eIF2α cells in the spinal cords of IFN-γCNS+;Perk+/+ mice compared with IFN-γCNS–;Perk+/+ mice at PID14. Error bars represent SD. n = 3. **P < 0.01 versus IFN-γCNS–;Perk+/+.